Mechanotransduction of shear stress: from ATP release to CFTR regulation

剪切应力的机械传导:从 ATP 释放到 CFTR 调节

基本信息

  • 批准号:
    7880885
  • 负责人:
  • 金额:
    $ 10.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-01 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In this application, Dr. Brian Button is proposing original research to investigate the mechanisms regulating shear stress-mediated ATP release. ATP release and autocrine/paracrine stimulation of purinergic receptors has been implicated in the regulation of a wide array of cell functions in numerous diverse cell types. A key role of purinergic signaling is the regulation of various ion transport processes, including the CFTR chloride channel. External mechanical stresses, including shear, compression, stretch, and cell swelling represent a ubiquitous mechanism to stimulate ATP release. However, the mechanisms responsible for mechanotransduction of external stresses to ATP release are unknown. Recently, the PI and collaborators discovered that the oscillatory nature of stress, such as experienced during normal breathing, is essential to stimulate ATP release. Furthermore, they found that the relationship between the magnitude of oscillatory stress and the rate of ATP release was steepest within the physiological range of normal breathing, whereas stronger forces generated weaker responses. These results lead the PI to hypothesize that cells can actively regulate the rate of ATP release during mechanical stimulation, thus protecting themselves from the potentially detrimental effect of unregulated ATP release and over-stimulation of purinoceptors. Preliminary results suggest that oscillatory stress-mediated ATP release occurs by a mechanism involving transmission of external and cilia beating-mediated forces through the cytoskeleton and exocytosis-dependent secretory pathways. The work outlined in this project is designed to systematically address several components of the mechanotransduction pathway involved in ATP release and establish its physiological role in the regulation of epithelial function. To achieve these objectives, the candidate will employ a variety of techniques grouped into three Specific Aims. Aim 1 will focus on the kinetic properties of stress-stimulated ATP release and identify the cytoskeletal elements involved in the vesicular-mediated process. Aim 2 will test the hypothesis that oscillatory shear stress of magnitude above physiological ranges reduces ATP release by altering the properties of the cell membrane. Finally, Aim 3 will test whether airway epithelia sense and respond to changes in the hydration status of the overlying mucus by internal stresses generated by cilia beating transmitted to the cytoskeleton. Together, these studies are designed to provide invaluable insights into the mechanism regulating ATP release in response to external and internal forces, which may potentially lead to the discovery of novel therapeutic approaches to modulate ATP release, important in such diseases as cystic fibrosis, where ATP release has been shown to stimulate mucus clearance. This K01 award will provide the foundation for Dr. Button to pursue his career goals of becoming an independent investigator and establishing scientific funding opportunities.
描述(由申请人提供): 在这项应用中,Brian Button博士提出了一项原创性研究,以探索剪切力介导的ATP释放的调节机制。ATP的释放和对嘌呤能受体的自分泌/旁分泌刺激参与了多种不同细胞类型的多种细胞功能的调节。嘌呤能信号的一个关键作用是调节各种离子转运过程,包括CFTR氯通道。外部机械应力,包括剪切、压缩、拉伸和细胞膨胀,是一种普遍存在的刺激ATP释放的机制。然而,外界压力对ATP释放的机械转导机制尚不清楚。最近,PI和他的合作者发现,压力的振荡性质,如在正常呼吸中所经历的,对于刺激ATP的释放是必不可少的。此外,他们发现,在正常呼吸的生理范围内,振荡应激的大小和ATP释放速率之间的关系最陡峭,而更强的力产生的反应更弱。这些结果导致PI假设细胞在机械刺激过程中可以主动调节ATP释放的速度,从而保护自己免受不受调节的ATP释放和对嘌呤受体过度刺激的潜在有害影响。初步结果表明,振荡应激介导的ATP释放是通过细胞骨架和胞吐依赖的分泌途径传递外部和纤毛搏动介导力的机制发生的。该项目旨在系统地研究参与ATP释放的机械转导途径的几个组成部分,并确定其在调节上皮功能中的生理作用。为了实现这些目标,应聘者将使用归类为三个具体目标的各种技术。目的1将重点研究应激刺激的ATP释放的动力学特性,并确定参与囊泡介导的过程的细胞骨架元件。目的2将验证这样的假设,即高于生理范围的幅度的振荡切应力通过改变细胞膜的属性来减少ATP的释放。最后,目标3将测试呼吸道上皮是否通过纤毛跳动传递到细胞骨架产生的内应力来感知并响应覆盖粘液的水合状态的变化。总之,这些研究旨在为调节ATP释放以响应外部和内部力量的机制提供宝贵的见解,这可能会导致发现调节ATP释放的新的治疗方法,这在囊性纤维化等疾病中非常重要,在囊性纤维化中,ATP的释放已被证明能刺激粘液清除。这一K01奖项将为巴顿博士追求他的职业目标--成为一名独立研究员并建立科学资助机会--奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRIAN M BUTTON其他文献

BRIAN M BUTTON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRIAN M BUTTON', 18)}}的其他基金

2023 Cilia, Mucus and Mucociliary Interactions GRC & GRS
2023 纤毛、粘液和粘液纤毛相互作用 GRC
  • 批准号:
    10601200
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
Project 3: Membrane-bound mucins on the airway surface ensure efficient mucus clearance and lung health
项目 3:气道表面的膜结合粘蛋白确保有效的粘液清除和肺部健康
  • 批准号:
    10684209
  • 财政年份:
    2022
  • 资助金额:
    $ 10.23万
  • 项目类别:
The role of mucus and pulmonary surface interactions in lung defense
粘液和肺表面相互作用在肺防御中的作用
  • 批准号:
    10463656
  • 财政年份:
    2015
  • 资助金额:
    $ 10.23万
  • 项目类别:
The role of mucus and pulmonary surface interactions in lung defense
粘液和肺表面相互作用在肺防御中的作用
  • 批准号:
    9305127
  • 财政年份:
    2015
  • 资助金额:
    $ 10.23万
  • 项目类别:
The role of mucus and pulmonary surface interactions in lung defense
粘液和肺表面相互作用在肺防御中的作用
  • 批准号:
    10656371
  • 财政年份:
    2015
  • 资助金额:
    $ 10.23万
  • 项目类别:
The role of mucus and pulmonary surface interactions in lung defense
粘液和肺表面相互作用在肺防御中的作用
  • 批准号:
    10204086
  • 财政年份:
    2015
  • 资助金额:
    $ 10.23万
  • 项目类别:
Mechanotransduction of shear stress: from ATP release to CFTR regulation
剪切应力的机械传导:从 ATP 释放到 CFTR 调节
  • 批准号:
    7447993
  • 财政年份:
    2008
  • 资助金额:
    $ 10.23万
  • 项目类别:
Mechanotransduction of shear stress: from ATP release to CFTR regulation
剪切应力的机械传导:从 ATP 释放到 CFTR 调节
  • 批准号:
    7809115
  • 财政年份:
    2008
  • 资助金额:
    $ 10.23万
  • 项目类别:
Mechanotransduction of shear stress: from ATP release to CFTR regulation
剪切应力的机械传导:从 ATP 释放到 CFTR 调节
  • 批准号:
    7634525
  • 财政年份:
    2008
  • 资助金额:
    $ 10.23万
  • 项目类别:
Core D: Mucus Biochemistry/Biophysics Core
核心 D:粘液生物化学/生物物理学核心
  • 批准号:
    10227488
  • 财政年份:
    2003
  • 资助金额:
    $ 10.23万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 10.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 10.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 10.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了